基因检测公司万基遗传（MYGN）周一盘后股价大幅下挫，截至发稿时跌幅达7.09%。这一显著跌幅紧随公司发布2025年第三季度财务业绩之后，投资者似乎对公司的表现感到失望。
根据万基遗传发布的财报显示，公司第三季度每股亏损0.29美元，这一数字可能远低于分析师的预期。尽管公司报告第三季度毛利率达到69.9%，但亏损状况仍然引发了市场的担忧。这表明公司在控制成本和提高运营效率方面可能面临挑战。
尽管财务业绩不佳，万基遗传仍然重申了其2025年的财务指引，这表明公司管理层对未来业务发展保持信心。然而，市场对此反应冷淡，投资者似乎更关注当前的财务表现而非未来预期。这种矛盾的信号可能是导致股价在盘后交易中大幅下跌的原因之一。接下来的交易日，投资者将密切关注公司股价的走势，以及管理层如何应对当前的财务挑战。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.